WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SF 744

Legislative bill overview

SF 744 would prohibit healthcare providers from performing certain medical interventions and therapies for gender dysphoria treatment in minors in Minnesota. The bill was introduced in January 2025 and referred to the Health and Human Services committee. Specific details about which therapies and procedures would be restricted are not provided in the available bill information.

Why is this important

This type of legislation directly affects healthcare access for transgender and gender non-conforming youth and has significant implications for medical practice standards in the state. The policy raises questions about parental rights, medical autonomy, clinical standards of care, and the appropriate role of government in medical decision-making.

Potential points of contention

  • Medical standards of care: Major medical organizations (AMA, AAP, ENDOCRINE SOCIETY) have published clinical guidelines supporting age-appropriate gender dysphoria treatment; restrictions could conflict with established medical protocols
  • Scope of "prohibition": Unclear which specific treatments are included—this ranges from social support/therapy to hormone therapy to surgery, which have different clinical contexts and age-appropriateness considerations
  • Parental authority vs. state authority: Tension between family medical decision-making rights and government regulation of healthcare choices
  • Interstate care implications: Youth may seek treatment in neighboring states, creating enforcement and equity questions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.